Excellergy Therapeutics is a startup, most recent round Acquired.
Excellergy Therapeutics is a startup. Excellergy Therapeutics has been acquired.
Excellergy Therapeutics develops best-in-class protein therapeutics aimed at rapidly relieving or preventing allergic-mediated diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.